Lu-177 PSMA Treatment in Cell Renal Carcinoma
NCT06959433
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Renal Cancer
Interventions
DRUG:
Lu-177 PSMA-617
Sponsor
Ankara University